'' Once Burned, twice Shy''We agree that J.Tripp in the past made some mistakes.The fact that he was alone in the decision making process, and his desire to bring these wonderfull tests to market faster, may have guided his decision making.
A new decision making process...
Today J.Tripp isn't alone anymore, he has two new big guy looking over his shoulder making sure he doesn't make bad moves.
-A new CCO(Chief Commercial Officer) David Byram, who came on board on July 12, 2018, and brought with him over 25 years of experience in his domain.
-And most of all (I love this guy) Dietrich Stephan who came on board August 15, 2018, he is a renowed Geneticist that know more about genenews tests than J.Tripp himself. He is also the ex CEO of LIFEX(make you wonder if he did quit his job as LIFEX CEO, just to be able to fully concentrate on helping GEN), after all Dietrich Stephan did say (QUOTE) '' Genenews has developed the ''Holy-Grail of cancer tests'' (END of QUOTE).
A renowed Geneticist tha said ''Holy-Grail of cancer tests'' what else need to be said.
The fact of the matter is today, every new partnerships that Genenews will embark on, will be check and recheck many time by this new team, J.Tripp(CEO), D.Byram(CFO), and D.Stephan (LIFEX ex CEO).
This process take time, but it is worth waiting for.